131 related articles for article (PubMed ID: 1521897)
1. Effect of dialyser composition and reuse on neutrophil count and elastase alpha-1 proteinase inhibitor complex formation.
Donovan KL; Pacholok S; Phillips A; Humes JL; Coles GA; Williams JD
Int J Artif Organs; 1992 Mar; 15(3):139-43. PubMed ID: 1521897
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
3. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone.
Amato M; Salvadori M; Bergesio F; Messeri A; Filimberti E; Morfini M
Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte elastase, beta-thromboglobulin, and C3d during acetate or bicarbonate hemodialysis with Hemophan compared to a cellulose acetate membrane.
Stegmayr BG; Esbensen K; Gutierrez A; Lundberg L; Nielsen B; Stroemsaeter CE; Wehle B
Int J Artif Organs; 1992 Jan; 15(1):10-8. PubMed ID: 1532382
[TBL] [Abstract][Full Text] [Related]
5. Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis.
Hörl WH; Schaefer RM; Heidland A
Am J Nephrol; 1985; 5(5):320-6. PubMed ID: 2414989
[TBL] [Abstract][Full Text] [Related]
6. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
Szepietowski T; Krajewska M
Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes.
Rosenkranz AR; Templ E; Traindl O; Heinzl H; Zlabinger GJ
Clin Exp Immunol; 1994 Nov; 98(2):300-5. PubMed ID: 7955536
[TBL] [Abstract][Full Text] [Related]
8. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
[TBL] [Abstract][Full Text] [Related]
9. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets].
Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I
Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
[TBL] [Abstract][Full Text] [Related]
11. [The effect of repeated use of cuprophane and polysulfone dialyzers during hemodialysis on the count of natural killer cells in blood].
Liszka M; Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z
Pol Arch Med Wewn; 1997 Mar; 97(3):224-31. PubMed ID: 9333768
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of myeloperoxidase and elastase are differentially regulated by hemodialysis membranes and anticoagulants.
Ono K; Ueki K; Inose K; Tsuchida A; Yano S; Nojima Y
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):341-9. PubMed ID: 11958287
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.
Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C
Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte activation during hemodialysis.
Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
[TBL] [Abstract][Full Text] [Related]
15. Influence of haemodialysis membranes on the release of granulocyte elastase.
Irvine L; Travers M; Simpson K; Lowe GD; Courtney JM
Int J Artif Organs; 1989 Aug; 12(8):502-4. PubMed ID: 2807595
[TBL] [Abstract][Full Text] [Related]
16. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
17. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
Vanholder RC; Ringoir SM
Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
[TBL] [Abstract][Full Text] [Related]
18. On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes.
Heierli C; Markert M; Lambert PH; Kuwahara T; Wauters JP
Nephrol Dial Transplant; 1988; 3(6):773-83. PubMed ID: 3147419
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility?
Grooteman MP; Nube MJ; van Limbeek J; Schoorl M; van Houte AJ
Nephrol Dial Transplant; 1996 Jun; 11(6):1073-8. PubMed ID: 8671971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
